The company also reported a 4.4 per cent drop in income at Rs 68.8 crore from Rs 72.02 crore a year ago.
RPG Life Sciences, which is into manufacturing and marketing of pharmaceutical products, did not attribute any reasons for the plunge in net income as well as sales.
For the full year, however, the company reported an over 11-fold spike in net income at Rs 11.62 crore against Rs 1 crore a year ago, while sales rose 18 per cent to Rs 274.54 crore from Rs 233.08 crore as its margins jumped by 250 bps to 8.6 per cent, the company said in a statement.
Focused brands like Minmin and Traicaine have grown by 62 per cent during the year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
